Medicinal Chemicals & Botanical Products·CHICAGO, IL
Summary Financials
Cresco Labs Inc. — SlamSEC
Revenue
$724.3M
-6.0% YoY
FY 2025
Adj. EBITDA
$166.4M
23.0% margin
FY 2025
Net Income
-$74.4M
-10.3% margin
FY 2025
EPS (Diluted)
-$0.22
FY 2025
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$137.6M
FY 2025
Total Debt
$472.7M
FY 2025
Net Debt
$335.1M
FY 2025
Enterprise Value
—
Debt / EBITDA
2.0x
FY 2025
EV / EBITDA
—
Employees
—
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use.